1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fabry Disease Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Enzyme Replacement Therapy (ERT)
1.2.3 Chaperone Treatment
1.2.4 Substrate Reduction Therapy (SRT)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fabry Disease Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Fabry Disease Treatment Market Perspective (2017-2028)
2.2 Fabry Disease Treatment Growth Trends by Region
2.2.1 Fabry Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fabry Disease Treatment Historic Market Size by Region (2017-2022)
2.2.3 Fabry Disease Treatment Forecasted Market Size by Region (2023-2028)
2.3 Fabry Disease Treatment Market Dynamics
2.3.1 Fabry Disease Treatment Industry Trends
2.3.2 Fabry Disease Treatment Market Drivers
2.3.3 Fabry Disease Treatment Market Challenges
2.3.4 Fabry Disease Treatment Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Fabry Disease Treatment Players by Revenue
3.1.1 Global Top Fabry Disease Treatment Players by Revenue (2017-2022)
3.1.2 Global Fabry Disease Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fabry Disease Treatment Revenue
3.4 Global Fabry Disease Treatment Market Concentration Ratio
3.4.1 Global Fabry Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fabry Disease Treatment Revenue in 2021
3.5 Fabry Disease Treatment Key Players Head office and Area Served
3.6 Key Players Fabry Disease Treatment Product Solution and Service
3.7 Date of Enter into Fabry Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Fabry Disease Treatment Breakdown Data by Type
4.1 Global Fabry Disease Treatment Historic Market Size by Type (2017-2022)
4.2 Global Fabry Disease Treatment Forecasted Market Size by Type (2023-2028) 5 Fabry Disease Treatment Breakdown Data by Application
5.1 Global Fabry Disease Treatment Historic Market Size by Application (2017-2022)
5.2 Global Fabry Disease Treatment Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Fabry Disease Treatment Market Size (2017-2028)
6.2 North America Fabry Disease Treatment Market Size by Country (2017-2022)
6.3 North America Fabry Disease Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Fabry Disease Treatment Market Size (2017-2028)
7.2 Europe Fabry Disease Treatment Market Size by Country (2017-2022)
7.3 Europe Fabry Disease Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Fabry Disease Treatment Market Size (2017-2028)
8.2 Asia-Pacific Fabry Disease Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Fabry Disease Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Fabry Disease Treatment Market Size (2017-2028)
9.2 Latin America Fabry Disease Treatment Market Size by Country (2017-2022)
9.3 Latin America Fabry Disease Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Fabry Disease Treatment Market Size (2017-2028)
10.2 Middle East & Africa Fabry Disease Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Fabry Disease Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Detail
11.1.2 Sanofi S.A. Business Overview
11.1.3 Sanofi S.A. Fabry Disease Treatment Introduction
11.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2017-2022)
11.1.5 Sanofi S.A. Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Fabry Disease Treatment Introduction
11.2.4 Takeda Revenue in Fabry Disease Treatment Business (2017-2022)
11.2.5 Takeda Recent Development
11.3 Amicus Therapeutics Inc.
11.3.1 Amicus Therapeutics Inc. Company Detail
11.3.2 Amicus Therapeutics Inc. Business Overview
11.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Introduction
11.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
11.3.5 Amicus Therapeutics Inc. Recent Development
11.4 ISU Abxis Co Ltd.
11.4.1 ISU Abxis Co Ltd. Company Detail
11.4.2 ISU Abxis Co Ltd. Business Overview
11.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Introduction
11.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
11.4.5 ISU Abxis Co Ltd. Recent Development
11.5 JCR Pharmaceuticals Co Ltd.
11.5.1 JCR Pharmaceuticals Co Ltd. Company Detail
11.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
11.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Introduction
11.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
11.5.5 JCR Pharmaceuticals Co Ltd. Recent Development
11.6 Protalix Biotherapeutics Inc.
11.6.1 Protalix Biotherapeutics Inc. Company Detail
11.6.2 Protalix Biotherapeutics Inc. Business Overview
11.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Introduction
11.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
11.6.5 Protalix Biotherapeutics Inc. Recent Development
11.7 Idorsia Pharmaceuticals Ltd.
11.7.1 Idorsia Pharmaceuticals Ltd. Company Detail
11.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
11.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Introduction
11.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
11.7.5 Idorsia Pharmaceuticals Ltd. Recent Development
11.8 Avrobio Inc.
11.8.1 Avrobio Inc. Company Detail
11.8.2 Avrobio Inc. Business Overview
11.8.3 Avrobio Inc. Fabry Disease Treatment Introduction
11.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
11.8.5 Avrobio Inc. Recent Development
11.9 Greenovation Biotech GmbH
11.9.1 Greenovation Biotech GmbH Company Detail
11.9.2 Greenovation Biotech GmbH Business Overview
11.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Introduction
11.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2017-2022)
11.9.5 Greenovation Biotech GmbH Recent Development
11.10 Moderna Therapeutics Inc.
11.10.1 Moderna Therapeutics Inc. Company Detail
11.10.2 Moderna Therapeutics Inc. Business Overview
11.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Introduction
11.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
11.10.5 Moderna Therapeutics Inc. Recent Development
11.11 Green Cross Pharma Pte Ltd.
11.11.1 Green Cross Pharma Pte Ltd. Company Detail
11.11.2 Green Cross Pharma Pte Ltd. Business Overview
11.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Introduction
11.11.4 Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
11.11.5 Green Cross Pharma Pte Ltd. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
